PNLIP and chronic myelogenous leukemia, BCR-ABL1 positive: Previous reports demonstrated that ROS levels are increased in CML primitive cells.7 Considering that PTL and DMAPT have been reported as ROS inducers in different cancer models,21 we assessed this effect in CML cells.